Idogen: Finds a way forward
Research Note
2019-06-18
10:13
Idogen shares soar roughly 40% following today’s announcement that they have established a new method for the development of their dendritic cell therapy. While it is still early stage, we have a positive view on today's news.
LS
Ludvig Svensson
Disclosures and disclaimers